Wednesday, July 8, 2026

pharma · Severe Obesity · UPC

Universe Pharmaceuticals

Universal Pharmaceuticals is a pharma organization headquartered in Silverwater, AU. It trades on NYSE under ticker UPC. Primary therapeutic focus areas include Severe Obesity. NovaPharmaNews links 1 clinical program(s),

Silverwater, AU HQ
1995 Founded
56 Employees
Public company Type
UPC · NYSE Ticker
Company details
Status
Public
HQ
Silverwater, AU
Founded
1995
Employees
56
Programs
1
Drugs
1
Patents
5

Quick answer

Universal Pharmaceuticals is a pharma organization headquartered in Silverwater, AU. It trades on NYSE under ticker UPC. Primary therapeutic focus areas include Severe Obesity. NovaPharmaNews links 1 clinical program(s), 0 drug profile(s), and 5 patent record(s) to this entity from public FDA, EMA, ClinicalTrials.gov, and USPTO sources.

Company snapshot

Universal Pharmaceuticals specialises in product development and contract manufacturing for private labels. We have more than 20 years' experience in the healthcare industry, so we can meet your needs whether you are a large or small supplier of heath food products.

  • 1 active pipeline program(s) linked via ClinicalTrials.gov.
  • 5 US patent(s) indexed to this assignee profile.
  • 1 trial update(s) in the last 12 months.

Public regulatory, clinical, patent, and corporate records for Universe Pharmaceuticals. Not investment advice.

Lead pipeline drugs

Active clinical programs

Momentum

Proprietary activity score for Universe Pharmaceuticals.

1 active signal

7 /100 +0 vs 30 days ago

Signal breakdown

  • Clinical trials 1 30d
  • Nova articles 0 30d
  • Patents filed 0 30d
  • FDA actions 0 30d
  • SEC filings 0 30d
  • Conference presentations 0 90d
  • Pipeline advances 0 30d

Recent activity

Latest pipeline, patent, and corporate events for Universe Pharmaceuticals.

  1. Clinical update

    Olive oil — Unknown

  2. Patent grant

    Hydrogen-delivering system for a bodily orifice

  3. Patent grant

    Hydrogen-enhanced transdermal system

  4. Patent grant

    Alleviating common cold and influenza symptoms with molecular hydrogen

  5. Patent grant

    Fusion proteins comprising IFN-alpha2b and TM-alpha1

View all clinical trial activity →

Quick answers

Common questions about this sponsor — for analysts and search.

  • What is Universe Pharmaceuticals?

    Universal Pharmaceuticals is a pharma organization headquartered in Silverwater, AU. It trades on NYSE under ticker UPC. Primary therapeutic focus areas include Severe Obesity. NovaPharmaNews links 1 clinical program(s), 0 drug profile(s), and 5 patent record(s) to this entity fr

  • Is Universe Pharmaceuticals publicly traded?

    Yes. Universe Pharmaceuticals is listed with ticker UPC on NYSE per SEC EDGAR records linked on this profile.

  • What drugs does Universe Pharmaceuticals develop or market?

    We link 1 drug profile(s) where Universe Pharmaceuticals is an originator or marketer in FDA or regional approval metadata. See the drug portfolio table on https://novapharmanews.com/companies/universe-pharmaceuticals-inc#company-drugs.

  • What are the latest developments for Universe Pharmaceuticals?

    In the last 12 months our linked public records show 1 trial program update(s) and 0 US patent grant(s) tied to this profile.

  • What therapeutic areas does Universe Pharmaceuticals focus on?

    Universe Pharmaceuticals focuses on Severe Obesity based on our analysis of their pipeline programs and drug development activities.

Therapeutic focus

Therapeutic area distribution

Pipeline concentration by therapeutic area from linked clinical programs.

Programs by therapeutic area

Others
2